CVS Health Corporation (LON:0HRS)
75.19
-0.64 (-0.84%)
At close: Dec 5, 2025
CVS Health Revenue
CVS Health had revenue of $102.24B USD in the quarter ending September 30, 2025, with 7.76% growth. This brings the company's revenue in the last twelve months to $391.69B, up 6.66% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$391.69B
Revenue Growth
+6.66%
P/S Ratio
0.25
Revenue / Employee
$1.31M
Employees
300,000
Market Cap
72.06B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
| Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
| Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
| Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
| Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
CVS Health News
- 1 day ago - CVS Health generates over $474 Billion in 2024 U.S. economic impact, supporting communities throughout the United States - PRNewsWire
- 1 day ago - CVS Health (CVS) Analyst Rating Update: Target Price Raised by Bernstein | CVS Stock News - GuruFocus
- 2 days ago - Aetna expands initiatives to simplify experiences for health care professionals and patients - PRNewsWire
- 2 days ago - 2 Soaring Healthcare Stocks to Buy and Hold for a Decade - The Motley Fool
- 3 days ago - CVS Accused Of Years Of Faulty Insulin Refills In $37.8 Million Settlement - Benzinga
- 4 days ago - CVS Health (CVS) Settles $37.76M Overbilling Allegations - GuruFocus
- 4 days ago - 17 dividend-stock bargains from a value manager with a stellar track record - Market Watch
- 4 days ago - CVS Health to pay $37.76M in settlement for insulin pens claims - Seeking Alpha